Bioasis Technologies Inc. V.BTI

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

TSXV:BTI - Post by User

Bioasis Technologies Inc. > Sadly, I Think It's Checkmate

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 17, 2023 9:08pm

100 Views

Post# 35229601

RE:RE:Sadly, I Think It's Checkmate

I hear you, OttawaPeter. I think I'm at peace on some level. I did my share. I think I've been right about xB3.

We've dealt with failure for years but this assassination is so very clinical, so perfect. If Rathjen had put the effort into succeeding as she did with this sellout, we'd probably be ok.

By the way, the WAIVER AND AMENDMENT AGREEMENT was included in the Dec 20 filings, the first "Other material contracts - English" document above the "Material change report - English" of the same date.

jd

<< Previous

Bullboard Posts

Next >>

Catch up with companies that got a Stanley Cup Playoffs boost